Nevin Shrimanker, MD
Pain Medicine · Wake Forest, NCNPI 1386828754
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,095 of the $14,148 with a category attached, or 85.5%. 36 manufacturers reported payments, led by Medtronic at 26.6% of the total.
Across 320 payments — averaging $44.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$4K
- Biotronik NRO, Inc.$2K
- Si-bone, Inc.$1K
- Boston Scientific$778
- Vertos Medical, Inc.$649
- plus $2K from 30 others
What the payments were for
- Travel & lodging$2,05315%
- Food & beverage$12,09585%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 51 | $3,763 |
| Abbott | 125 | $3,668 |
| Biotronik NRO, Inc. | 25 | $1,663 |
| Si-bone, Inc. | 9 | $1,204 |
| Boston Scientific | 11 | $778 |
| Vertos Medical, Inc. | 15 | $649 |
| Saluda Medical Americas, Inc. | 7 | $378 |
| Nevro Corp. | 4 | $315 |
| Collegium Pharmaceutical, Inc. | 17 | $314 |
| Globus Medical | 3 | $275 |
| Amgen | 5 | $184 |
| AbbVie | 6 | $145 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $98 |
| Stryker | 2 | $70 |
| Arbor Pharmaceuticals, Inc. | 4 | $64 |
| Averitas Pharma Inc. | 2 | $59 |
| Forte Bio-pharma LLC | 4 | $56 |
| Nalu Medical, Inc. | 2 | $49 |
| GRT US Holding, Inc. | 2 | $48 |
| Painteq LLC | 2 | $37 |
| Vertex | 1 | $33 |
| Scilex Pharmaceuticals Inc. | 2 | $28 |
| Merck | 2 | $28 |
| Tersera Therapeutics LLC | 2 | $28 |
| MML US, Inc. | 1 | $26 |
| Virtus Pharmaceuticals LLC | 1 | $24 |
| Valinor Pharma, LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Sonex Health, Inc. | 1 | $20 |
| Masimo Corporation | 1 | $18 |
| Pfizer | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
| Avanos Medical | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,776
- Prospera$1,009
- IFUSE IMPLANT SYSTEM$764
- Proclaim Family of SCS IPGs$565
- Senza$530
- INTELLIS$498
- Proclaim IPG$317
- Intracept$260
- ADAPTIVESTIM$219
- GENERAL - THERAPIES$155
- OSTEOCOOL RF ABLATION SYSTEM$136
- Evoke$132
- VECTRIS SURESCAN$131
- BIOTRONIK$129
- AIMOVIG$125
- SPECTRA WAVEWRITER$105
- mild Device Kit$104
How this compares
$14,148 in reported general payments places this provider in the 85th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 27 | $15,677 |
| NucyntaTapentadol Hcl | 15 | $14,968 |
| Buprenorphine | 51 | $10,118 |
| Xtampza ErOxycodone Myristate | 14 | $7,808 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 261 | $6,837 |
| SavellaMilnacipran Hcl | 11 | $5,262 |
| Gabapentin | 228 | $4,429 |
| Oxycodone Hcl | 158 | $3,565 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 163 | $2,394 |
| Tramadol Hcl ErTramadol Hcl | 45 | $2,150 |
| Fentanyl | 13 | $1,753 |
| Lidocaine | 13 | $1,577 |
| Duloxetine Hcl | 112 | $1,557 |
| Morphine Sulfate ErMorphine Sulfate | 59 | $1,348 |
| Pregabalin | 109 | $1,296 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er | $314 | $22,77529 claims |
| AbbVieSavella | $145 | $5,26211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 182 pain medicine providers in North Carolina.
Other pain medicine in Wake Forest
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- Javid BakshAsheville$116K
- David ZubLeland$97K
- James DeeringCharlotte$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.